Abstract
Objective
Calcium desensitization plays an important part in the pathophysiology of septic myocardial depression. We postulated that levosimendan, a new calcium sensitizer, would be beneficial in sepsis-induced cardiac dysfunction.
Design and setting
Prospective, randomized, controlled study in two university hospital intensive care units
Patients and participants
Twenty-eight patients with persisting left ventricular dysfunction related to septic shock after 48 h of conventional treatment including dobutamine (5 µg/kg per minute).
Interventions
After 48 h of conventional treatment patients were randomized to receive a 24-h infusion of either levosimendan (0.2 µg/kg per minute, n=15) or dobutamine (5 µg/kg per minute, n=13).
Measurements and results
Data from right heart catheterization, echocardiography, gastric tonometry, laser-Doppler flowmetry, and lactate concentrations and creatinine clearance were obtained before and after the 24-h drug infusion. Dobutamine did not change systemic or regional hemodynamic variables. By contrast, at the same mean arterial pressure levosimendan decreased pulmonary artery occlusion pressure and increased cardiac index. Levosimendan decreased left ventricular end-diastolic volume and increased left ventricular ejection fraction. Levosimendan increased gastric mucosal flow, creatinine clearance, and urinary output while it decreased lactate concentrations.
Conclusions
These findings show that levosimendan improves systemic hemodynamics and regional perfusion in patients with septic cardiac dysfunction under conditions where administration of 5 µg/kg dobutamine per minute is no longer efficacious. Accordingly, our results suggest that levosimendan can be an alternative to the strategy of increasing the dose of dobutamine under such conditions.
Similar content being viewed by others
References
Parker MM, Shetlander J, Bacharach SL, Green MV, Natanson C, Frederick TM, Damske BA, Parrillo JE (1984) Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 100:483–490
Parker MM, McCarthy KE, Ognibene FP, Parrillo JE (1990) Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 97:126–131
Parillo JE (1993) Pathogenetic mechanisms of septic shock. N Engl J Med 328:1471–1477
Silverman HJ, Peneranda R, Orens JB, Lee NH (1993) Impaired beta-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: Association with myocardial hyporesponsiveness to catecholamines. Crit Care Med 21:31–39
Kumar A, Thota V, Dee L, Olson J, Uretz E, Parrillo JE (1996) Tumor necrosis factor-alpha and interleukin 1-beta are responsible for depression of in vitro myocardial cell contractility induced by serum from humans with septic shock. J Exp Med 183:949–958
Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL (1993) Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in adult mammalian heart. J Clin Invest 92:2303–2312
Goldhaber JI, Kim KH, Natterson PD, Lawrence T, Yang P, Weiss JN (1996) Effects of TNF-alpha on [Ca2+] and contractility in isolated adult rabbit ventricular myocytes. Am J Physiol 271 [Suppl 4]: H 1499–1505 g
Tavernier B, Mebazaa A, Mateo P, Sys S, Ventura-Clapier R, Veksler V (2001) Phosphorilation-dependent alteration in myofilament Ca2+ sensitivity but normal mitochondrial function in septic heart. Am J Respir Crit Care Med 163:362–367
Shah AM, Spurgeon HA, Sollott S, Talo A, Lakatta EG (1994) 8Bromo-cGMP reduces the myofilament response to Ca2+ in intact cardiac myocytes. Circ Res 74:970–978
Zhong J, Hwang T, Adams H, Rubin L (1997) Reduced L-type calcium current in ventricular myocites from endotoxemic guinea pigs. Am J Physiol 273:H2312–H2324
Hollenberg SM, Ahrens TS, Annane D, Astiz ME, Chalfin DB, Dasta JF, Heard SO, Martin C, Napolitano LM, Susla GM, Totaro R, Vincent JL, Zanotti-Cavazzoni S (2004) Practice parameters for hemodynamic support of sepsis in adult patient: 2004 update. Crit Care Med 32:1928–1948
Ming MJ, Hu DY, Chen HS, Liu LM, Nan X, Lu RO (2000) Effects of MCI-154, a calcium sensitizer on cardiac dysfunction in endotoxic shock in rabbits. Shock 13:459–463
Usta C, Puddu PE, Papalia U, De Santis V, Vitale D, Tritapepe L, Mazzesi G, Mirali F, Ozdem SS (2004) Comparison of the inotropic effects of levosimendan, rolipram and dobutamine on human atrial trabeculae. J Cardiovasc Pharmacol 44:622–625
Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, Harjola VP, Mitrovic V, Abdalla M, Sandell EP, Lehtonen L; Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study (2002) Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 360:196–202
Duranteau J, Sitbon P, Teboul JL, Vicaut E, Anguel N, Richard C, Samii K (1999) Effects of epinephrine, norepinephrine or combination of norepinephrine and dobutamine on gastric mucosa in septic shock. Crit Care Med 27:893–900
Poelaert J, Declerck C, Vogelaers D, Colardyn F, Visser CA (1997) Left ventricular systolic and diastolic function in septic shock. Intensive Care Med 23:553–560
Yasuda S, Lew WYW (1997) Lipopolysaccharide depresses cardiac contractility and β-adrenergic contractile response by decreasing myofilament response to Ca2+ in cardiac myocytes. Circulation Res 81:1011–1020
Bernardin G, Kisoka RL, Delporte C, Robberecht P, Vincent JL (2003) Impairment of beta-adrenergic signaling in healthy peripheral blood mononuclear cells exposed to serum from patients with septic shock: involvement of the inhibitory pathway of adenylyl cyclase stimulation. Shock 19:108–112
Matsuda N, Hattori Y, Akaishi Y, Suzuki Y, Kemmotsu O, Gando S (2000) Impairment of cardiac beta-adrenoceptor cellular signaling by decreased expression of G (s alpha) in septic rabbits. Anesthesiology 93:1465–1473
Levy B, Nace L, Bollaert PE, Dousset B, Mallie JP, Larcan A (1999) Comparison of systemic and regional effects of dobutamine and dopexamine in norepinephrine-treated septic shock. Intensive Care Med 25:942–948
Creteur J, De Backer D, Vincent JL (1999) A dobutamine test can disclose hepatosplanchnic hypoperfusion in septic patients. Am J Respir Crit Care Med 160:839–845
Teboul JL, Mercat A, Lenique F, Berton C, Richard C (1998) Value of the venous-arterial PCO2 gradient to reflect the oxygen supply to demands in humans: effects of dobutamine. Crit Care Med 26:1007–1010
Hung J, Lew WY (1993) Cellular mechanisms of endotoxin-induced myocardial depression in rabbits. Circ Res 73:125–134
Hasenfuss G, Pieske B, Castell M, Kretschmann B, Maier LS, Just H (1998) Influence of the novel inotropic agents levosimendan on isometric tension and calcium cycling in failing human myocardium. Circulation 98:2141–2147
Oldner A, Konrad D, Weitzberg E, Rudehill A, Rossi P, Wanacek M (2001) Effect of levosimendan a novel inotropic calcium-sensitizing drug, in experimental septic shock. Crit Care Med 29:2185–2193
Nieminen MS, Akkila J, Hasenfuss G, Kleber FX, Lehtonen LA, Mitrovic V, Nyquist O, Remme WJ (2000) Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure. J Am Coll Cardiol 36:1903–1912
Slawsky MT, Colucci WS, Gottlieb SS, Greenberg BH, Haeusslein E, Hare J, Hutchins S, Leier CV, LeJemtel TH, Loh E, Nicklas J, Ogilby D, Singh BN, Smith W (2000) Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Circulation 102:2222–2227
Ukkonen H, Saraste M, Akkila J, Knuuti J, Karanko M, Iida H, Lehikonen P, Nagren K, Lehtonen L, Voipio-Pulkki LM (2000) Myocardial efficiency during levosimendan infusion in congestive heart failure. Clin Pharmacol Ther 68:522–531
Kaheinen P, Pollesello P, Levijoki J, Haikala H (2001) Levosimendan increases diastolic coronary flow in isolated guinea-pig heart by opening ATP-sensitive potassium channels. J Cardiovasc Pharmacol 37:367–374
Sibbald WJ, Paterson NA, Holliday RL, Anderson RA, Lobb TR, Duff JH (1978) Pulmonary hypertension in sepsis: measurement by the pulmonary artery diastolic-pulmonary wedge pressure gradient and the influence of passive and active factors. Chest 73:583–591
Kimchi A, Ellrodt GA, Berman DS, Riedinger MS, Swan HJ, Murata GH (1984) Right ventricular performance in septic shock: a combined radionuclide and hemodynamic study. J Am Coll Cardiol 4:945–951
Fiddian-Green RG (1993) Associations between intramucosal acidosis in the gut and organ failure. Crit Care Med 21 [Suppl]:S103–S107
Shepherd AP, Riedel GL, Maxwell LC, Kiel JW (1984) Selective vasodilators redistribute intestinal blood flow and depress oxygen uptake. Am J Physiol 247:G377–G384
Maynard ND, Bihari DJ, Dalton RN, Smithies MN, Mason RC (1995) Increasing splanchnic blood flow in the critically ill. Chest 108:1648–1654
Lebuffe G, Levy B, Nevière R, Chagnon JL, Perrigault PF, Duranteau J, Edouard A, Teboul JL, Vallet B (2002) Dobutamine and gastric-to-arterial carbon dioxide gap in severe sepsis without shock. Intensive Care Med 28:265–271
Pagel PS, Hettrick DA, Warltier DC (1996) Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anesthetized dogs. Br J Pharmacol 119:609–615
Scarpace PJ, Abrass IB (1982) Desensitization of adenylate cyclase and down regulation of beta adrenergic receptors after in vivo administration of beta agonist. J Pharmacol Exp Ther 223:327–331
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was funded by an independent research grant from the Department of Anesthesiology and Intensive Care of the University of Rome La Sapienza
Rights and permissions
About this article
Cite this article
Morelli, A., De Castro, S., Teboul, JL. et al. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med 31, 638–644 (2005). https://doi.org/10.1007/s00134-005-2619-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-005-2619-z